Clinical Trial Update: Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of amifampridine on neuromuscular transmission in patients treated with onabotulinumtoxinA. The trial status shows completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Botulism

Drugs mentioned

• Amifampridine (amifampridine)
• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Botulism, Iatrogenic Botulism | Phase 1 | Status: COMPLETED